Meningococcal (Group A & C) Polysaccharide Vaccine + Lactose

Information about Meningococcal (Group A & C) Polysaccharide Vaccine + Lactose

Meningococcal (group a & c) polysaccharide vaccine + lactose uses

Meningococcal (Group A & C) Polysaccharide Vaccine+Lactose is used in the treatment of Meningococcal disease.

How meningococcal (group a & c) polysaccharide vaccine + lactose works

This contains Meningococcal Polysaccharide A & C Vaccine which helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections. It also contains Lactose, that is added to the vaccine as a stabilizer for the solution.

Common side effects of meningococcal (group a & c) polysaccharide vaccine + lactose

Available Medicine for Meningococcal (Group A & C) Polysaccharide Vaccine + Lactose

  • ₹450
    Biomed Pharmaceuticals
    1 variant(s)

Content on this page was last updated on 05 September, 2023, by Dr. Varun Gupta (MD Pharmacology)